Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...

Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.